arrow_back Back to App

Nullifying Mifepristone Abortion Pill Access Changes

This bill aims to reverse the changes made by the Food and Drug Administration (FDA) in January 2023 regarding the access rules for the abortion pill mifepristone. If passed, the rules for accessing this medication would revert to their state before January 2023, potentially affecting how patients obtain prescriptions and the drug itself.
Key points
Reversal of FDA's January 2023 decisions on mifepristone.
Restoration of previous access rules for the abortion pill mifepristone.
Prohibition on the Department of Health and Human Services from implementing similar changes in the future.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_383
Sponsor: Rep. Harshbarger, Diana [R-TN-1]
Process start date: 2023-01-17
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_383.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-01-17.

What are the main provisions?

Key points include:

  • Reversal of FDA's January 2023 decisions on mifepristone.
  • Restoration of previous access rules for the abortion pill mifepristone.
  • Prohibition on the Department of Health and Human Services from implementing similar changes in the future.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Harshbarger, Diana [R-TN-1].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.

CATEGORIES

Health